IP Library › Assignment 021305/0565
Patent Assignment
Reel/Frame 021305/0565

Assignment of Assignor's Interest

Recorded: 2008-07-28 Pages: 2
Assignor
SCOTT, ANDREW MARK
Executed: 2008-07-22
Assignee
LUDWIG INSTITUTE FOR CANCER RESEARCH
605 THIRD AVENUE, NEW YORK, NEW YORK, 10158
Covered Property (1)
EphA3 Antibodies for the Treatment of Solid Tumors
Patent: 8,637,016 →
Application: 12/045,589 →
Publication: US 2008/0286272
Related Assignments (11)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 28, 2008
From: LACKMANN, MARTIN
To: MONASH UNIVERSITY
Reel/Frame 021305/0563 →
Assignment of Assignor's Interest Jul 28, 2008
From: TO, CATHERINE
To: MONASH UNIVERSITY
Reel/Frame 021305/0490 →
Assignment of Assignor's Interest Jul 28, 2008
From: MURONE, CARMELINA
To: LUDWIG INSTITUTE FOR CANCER RESEARCH
Reel/Frame 021305/0488 →
Assignment of Assignor's Interest Jul 28, 2008
From: BEBBINGTON, CHRISTOPHER R.; YARRANTON, GEOFFREY T.
To: KALOBIOS PHARMACEUTICALS, INC.
Reel/Frame 021305/0428 →
Security Interest May 23, 2016
From: KALOBIOS PHARMACEUTICALS, INC.
To: BLACK HORSE CAPITAL, LP
Reel/Frame 038788/0266 →
Security Interest Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
Change of Name Nov 6, 2017
From: KALOBIOS PHARMACEUTICALS, INC.
To: HUMANIGEN, INC.
Reel/Frame 044767/0814 →
Release of Security Interest Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →
Release of Security Interest Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045788/0148 →
Security Interest Jul 16, 2019
From: HUMANIGEN, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 049769/0067 →
Release of Security Interest Jun 12, 2020
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: HUMANIGEN, INC.
Reel/Frame 052920/0631 →